Salpingitis

Summary

Salpingitis (MONDO:0003619) is a disease (an umbrella term covering 6 Mondo subtypes) and 1 clinical trial. Top therapeutic interventions include gonadorelin acetate and triptorelin. A subtype of pelvic inflammatory disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Umbrella term: 6 Mondo subtypes
• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	salpingitis
Mondo ID	MONDO:0003619
MeSH	D012488
DOID	DOID:5733
NCIT	C26880
SNOMED CT	88157006
UMLS	C0036130
MedGen	20646
Is cancer (heuristic)	no

Also known as: fallopian tube inflammation · inflammation of fallopian tube

Disease family

This is a subtype of pelvic inflammatory disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › reproductive system disorder › female reproductive system disorder › pelvic inflammatory disease › salpingitis

Related subtypes (3): acute female pelvic peritonitis, parametritis, Fitz-Hugh-Curtis syndrome

Subtypes (6): tuberculous salpingitis, salpingo-oophoritis, acute salpingitis, chronic salpingitis, pyosalpinx, gonococcal salpingitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
PHASE1/PHASE2	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04071574	PHASE1/PHASE2	COMPLETED	Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility

Drugs tested across these trials (top 30)

Molecule	Max phase	Trials referencing
GONADORELIN ACETATE	4	1
TRIPTORELIN	4	1
CHEMBL2370644	0	1